Trial Profile
Anthrax vaccine adsorbed; human reactogenecity and immunogenecity trial to address change in route of administration and dose reduction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Anthrax vaccine (Primary)
- Indications Anthrax
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Acronyms ADA
- 16 Jul 2012 Quality of life results published in Vaccine.
- 13 Sep 2009 Results were presented at ICAAC 2009.
- 20 Dec 2008 Centers for Disease Control and Prevention will complete further data analysis in 2009.